Aptevo Therapeutics (APVO) Goodwill (2015 - 2016)

Aptevo Therapeutics (APVO) posted Goodwill of $29.2 million for Q2 2016, little changed sequentially from $29.2 million in Q1 2016.

Aptevo Therapeutics (APVO) Goodwill (2015 - 2016) Analysis & Trends

Aptevo Therapeutics has reported Goodwill for 2 years, with the latest figure at $29.2 million in Q2 2016.

Quarterly Goodwill changed N/A year-over-year to $29.2 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $29.2 million (changed N/A YoY) and the FY2015 annual result came in at $29.2 million, changed N/A from the prior year.
Goodwill held at $29.2 million in Q2 2016 per APVO's latest filing, from $29.2 million in the prior quarter.
Over five years, Goodwill peaked at $29.2 million in Q4 2015 and troughed at $29.2 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	140.14 Bn	132.29 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	87.02 Bn	79.03 Bn	3.93 Bn
3	Argenx Se	65.30 Bn	60.12 Bn	1.37 Bn
4	Moderna	60.84 Bn	55.70 Bn	52.00 Mn
5	BeOne Medicines	42.15 Bn	37.06 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.49 Bn	28.18 Bn	992.69 Mn
7	BioNTech SE	28.78 Bn	10.38 Bn	668.28 Mn
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn
9	Royalty Pharma	27.14 Bn	26.31 Bn	-
10	Aptevo Therapeutics	3.34 Mn	-6.46 Mn	-

Download Data